![]() F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. | ||
Founding Date | Founding Date 2007 | Founding Date 2006 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Cambridge, US HQ | Locations Cambridge, GB HQ Wien, AT Cambridge, US |
Employees | Employees 324187% increase | Employees 39 |
Financial | ||
Revenue (est.) | Revenue (est.) $236.2m (FY, 2025) | Revenue (est.) £18.7m (FY, 2018) |
Net income | Net income ($5.3m) (FY, 2025) | Net income (£2.6m) (FY, 2018) |

F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
View company